US secures 600,000 more doses of COVID-19 therapy Sotrovimab
The United States has agreed to buy 600,000 more doses of GSK and Vir Biotechnology's… Read More
3 years ago
The United States has agreed to buy 600,000 more doses of GSK and Vir Biotechnology's… Read More
GlaxoSmithKline on Thursday said that a lab analysis of Sotrovimab, the antibody-based COVID-19 therapy it… Read More
ABU DHABI: The UAE was among the first countries of the world to receive a… Read More
The treatment, sotrovimab, received an emergency use authorization from the US Food and Drug Administration… Read More